Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 4Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Parathyroid Neoplasms 2Ovarian Neoplasms 2Otorhinolaryngologic Neoplasms 2Osteosarcoma 2Mixed Tumor, Mesodermal 2Mesothelioma, Cystic 2Mesothelioma 2Liposarcoma 2Leiomyosarcoma 2Kidney Neoplasms 2Hemangiosarcoma 2Head and Neck Neoplasms 2Fibrosarcoma 2Esophageal Neoplasms 2Colorectal Neoplasms 2Chondrosarcoma 2Carcinoma, Small Cell 2Breast Neoplasms 2Adenosarcoma 2Tracheal Neoplasms 1Thymoma 1Solitary Pulmonary Nodule 1Solitary Fibrous Tumor, Pleural 1Small Cell Lung Carcinoma 1Pulmonary Sclerosing Hemangioma 1

Interventions

Carboplatin 12Pemetrexed 11pembrolizumab 10Paclitaxel 6Cisplatin 6Erlotinib Hydrochloride 5Docetaxel 5Nivolumab 4Gefitinib 4spartalizumab 3osimertinib 3Gemcitabine 3EC145 3Crizotinib 3Afatinib 3technetium 99m etarfolatide 2pralsetinib 2fludarabine 2cemiplimab 2brigatinib 2alpha-2'-deoxythioguanosine 2aldesleukin 2Vinorelbine 2Radiotherapy 2Quality of Life 2MORAb-202 2Immunotherapy 2Drug Therapy 2Cyclophosphamide 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × belinostat × Thoracic × Clear all
NCT01310244 2020-01-06

MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLC

Acrotech Biopharma Inc.

Phase 1/2 Completed
23 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡